Dental lead generation produces inquiries from prospective patients interested in dental services. Programs may generate general new-patient demand or focus on procedures such as implants, cosmetic dentistry, orthodontics or other services.
Because procedure value varies considerably, practices should evaluate acquisition economics by treatment category rather than using one blended cost-per-lead target.
Lead Categories
Potential campaigns include:
- general dentistry
- implants
- cosmetic dentistry
- dentures
- orthodontics
- emergency dental
- other practice-specific services
Lead Products
| Product | Deliverable |
|---|---|
| Form lead | Patient contact/inquiry |
| Phone lead | Inbound tracked call |
| Qualified lead | Agreed factual criteria |
| Appointment | Scheduled consultation |
| Live transfer | Immediate conversation |
Qualification
Qualification should remain limited to appropriate administrative criteria.
A marketing vendor should not make clinical determinations.
Possible nonclinical criteria include:
- geography
- service requested
- scheduling availability
- whether the inquiry is for the prospective patient
- other practice-approved administrative factors
Appointment Economics
For lead sources that schedule directly, distinguish:
booked → confirmed → attended → treatment accepted → acquired patient
A cheap appointment with a high no-show rate may be less valuable than a more expensive source with stronger patient intent.
Source Transparency
Understand:
- ad channel
- landing page
- brand shown
- shared/exclusive terms
- lead age
- follow-up process
Patient Data
If a marketing workflow eventually involves information that is PHI and a vendor acts on behalf of a covered dental practice, the HIPAA/business-associate analysis depends on the actual relationship and information flow. HHS's business-associate guidance should govern those determinations rather than generic vendor labels.
Choosing a Provider
Compare procedure specialization, source transparency, geographic controls, exclusivity, appointment quality, attribution and downstream patient economics.